{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:48:02Z","timestamp":1791863282454,"version":"4.3.4"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K23864"],"award-info":[{"award-number":["23K23864"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJCR24B3"],"award-info":[{"award-number":["JPMJCR24B3"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23bm1323001"],"award-info":[{"award-number":["JP23bm1323001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23bm1123006"],"award-info":[{"award-number":["JP23bm1123006"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regenerative Therapy"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.reth.2026.101172","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:24:58Z","timestamp":1789853098000},"page":"101172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Genetically engineered hypoimmunogenic iPSCs: Strategies and considerations for clinical applications"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0974-2233","authenticated-orcid":false,"given":"Jason K.M.","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2619-7441","authenticated-orcid":false,"given":"Akitsu","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reth.2026.101172_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202400072","article-title":"iPS cell therapy 2.0: preparing for next-generation regenerative medicine","volume":"46","author":"Hui","year":"2024","journal-title":"BioEssays News Rev Mol Cell Dev Biol"},{"key":"10.1016\/j.reth.2026.101172_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/scd.2014.0136","article-title":"Do human leukocyte antigen-typed cellular therapeutics based on induced pluripotent stem cells make commercial sense?","volume":"24","author":"Bravery","year":"2015","journal-title":"Stem Cell Dev"},{"key":"10.1016\/j.reth.2026.101172_bib3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s12015-021-10262-3","article-title":"Review of the current trends in clinical trials involving induced pluripotent stem cells","volume":"18","author":"Kim","year":"2022","journal-title":"Stem Cell Rev Rep"},{"key":"10.1016\/j.reth.2026.101172_bib4","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.1138140","article-title":"CRISPR provides acquired resistance against viruses in prokaryotes","volume":"315","author":"Barrangou","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.reth.2026.101172_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mib.2017.05.008","article-title":"Diversity, classification and evolution of CRISPR-Cas systems","volume":"37","author":"Koonin","year":"2017","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.reth.2026.101172_bib6","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nrmicro3569","article-title":"An updated evolutionary classification of CRISPR-Cas systems","volume":"13","author":"Makarova","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.reth.2026.101172_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133661","article-title":"Occurrence and diversity of CRISPR-Cas systems in the genus bifidobacterium","volume":"10","author":"Briner","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.reth.2026.101172_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.124054","article-title":"CRISPR-Cas for genome editing: classification, mechanism, designing and applications","volume":"238","author":"Bhatia","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.reth.2026.101172_bib9","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/emboj.2011.41","article-title":"Cas3 is a single-stranded DNA nuclease and ATP-dependent helicase in the CRISPR\/Cas immune system","volume":"30","author":"Sinkunas","year":"2011","journal-title":"EMBO J"},{"key":"10.1016\/j.reth.2026.101172_bib10","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.molcel.2019.03.014","article-title":"Introducing a spectrum of long-range genomic deletions in human embryonic stem cells using type I CRISPR-Cas","volume":"74","author":"Dolan","year":"2019","journal-title":"Mol Cell"},{"key":"10.1016\/j.reth.2026.101172_bib11","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1038\/s41467-019-13226-x","article-title":"CRISPR-Cas3 induces broad and unidirectional genome editing in human cells","volume":"10","author":"Morisaka","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.reth.2026.101172_bib12","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.stemcr.2023.07.007","article-title":"Dual CRISPR-Cas3 system for inducing multi-exon skipping in DMD patient-derived iPSCs","volume":"18","author":"Kita","year":"2023","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.reth.2026.101172_bib13","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1038\/s41467-024-48598-2","article-title":"Structure and genome editing of type I-B CRISPR-Cas","volume":"15","author":"Lu","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.reth.2026.101172_bib14","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.molcel.2021.12.032","article-title":"Cas11 enables genome engineering in human cells with compact CRISPR-Cas3 systems","volume":"82","author":"Tan","year":"2022","journal-title":"Mol Cell"},{"key":"10.1016\/j.reth.2026.101172_bib15","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1093\/nar\/gkab348","article-title":"Genome editing in mammalian cells using the CRISPR type I-D nuclease","volume":"49","author":"Osakabe","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.reth.2026.101172_bib16","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nbt.4192","article-title":"Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements","volume":"36","author":"Kosicki","year":"2018","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.reth.2026.101172_bib17","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1038\/ncomms7244","article-title":"Multiplex CRISPR\/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy","volume":"6","author":"Ousterout","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.reth.2026.101172_bib18","article-title":"Precise large-fragment deletions in mammalian cells and mice generated by dCas9-controlled CRISPR\/Cas3","volume":"10","author":"Li","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.reth.2026.101172_bib19","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable Dual-RNA\u2013Guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.reth.2026.101172_bib20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s12539-018-0298-z","article-title":"Review of CRISPR\/Cas9 sgRNA design tools","volume":"10","author":"Cui","year":"2018","journal-title":"Interdiscip Sci Comput Life Sci"},{"key":"10.1016\/j.reth.2026.101172_bib21","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1158\/1078-0432.CCR-16-1300","article-title":"Multiplex genome editing to generate universal CAR T cells resistant to PD1 inhibition","volume":"23","author":"Ren","year":"2017","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.reth.2026.101172_bib22","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","article-title":"Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system","volume":"163","author":"Zetsche","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.reth.2026.101172_bib23","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1007\/s11033-023-08239-1","article-title":"An update on CRISPR-Cas12 as a versatile tool in genome editing","volume":"50","author":"Senthilnathan","year":"2023","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.reth.2026.101172_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nbt.3737","article-title":"Multiplex gene editing by CRISPR-Cpf1 using a single crRNA array","volume":"35","author":"Zetsche","year":"2017","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.reth.2026.101172_bib25","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.reth.2026.101172_bib26","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/s41573-020-0084-6","article-title":"Base editing: advances and therapeutic opportunities","volume":"19","author":"Porto","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.reth.2026.101172_bib27","article-title":"A highly specific CRISPR-Cas12j nuclease enables allele-specific genome editing","volume":"9","author":"Wang","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.reth.2026.101172_bib28","doi-asserted-by":"crossref","first-page":"9499","DOI":"10.1038\/s41467-025-64562-0","article-title":"Noncanonical target-strand cytosine base editing via engineered Un1Cas12f1 platform","volume":"16","author":"Song","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.reth.2026.101172_bib29","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1038\/s41467-023-39087-z","article-title":"A Cas3-base editing tool for targetable in vivo mutagenesis","volume":"14","author":"Zimmermann","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.reth.2026.101172_bib30","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nmeth.4327","article-title":"CRISPR-STOP: gene silencing through base-editing-induced nonsense mutations","volume":"14","author":"Kuscu","year":"2017","journal-title":"Nat Methods"},{"key":"10.1016\/j.reth.2026.101172_bib31","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.reth.2026.101172_bib32","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/s41587-019-0254-4","article-title":"Adenine base editors catalyze cytosine conversions in human cells","volume":"37","author":"Kim","year":"2019","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.reth.2026.101172_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41589-022-01163-8","article-title":"Engineering a precise adenine base editor with minimal bystander editing","volume":"19","author":"Chen","year":"2023","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.reth.2026.101172_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-026-03045-z","article-title":"Precise, minimally evolved adenine base editors generated through mutation reversion analysis","author":"Evanoff","year":"2026","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.reth.2026.101172_bib35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.reth.2026.101172_bib36","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1007\/s00018-012-1204-1","article-title":"Gene knockout and knockin by zinc-finger nucleases: current status and perspectives","volume":"70","author":"Hauschild-Quintern","year":"2012","journal-title":"Cell Mol Life Sci CMLS"},{"key":"10.1016\/j.reth.2026.101172_bib37","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/s41592-023-01949-1","article-title":"Efficient high-precision homology-directed repair-dependent genome editing by HDRobust","volume":"20","author":"Riesenberg","year":"2023","journal-title":"Nat Methods"},{"key":"10.1016\/j.reth.2026.101172_bib38","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1038\/s41467-023-39137-6","article-title":"Template-jumping prime editing enables large insertion and exon rewriting in vivo","volume":"14","author":"Zheng","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.reth.2026.101172_bib39","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41587-022-01527-4","article-title":"Drag-and-drop genome insertion of large sequences without double-strand DNA cleavage using CRISPR-directed integrases","volume":"41","author":"Yarnall","year":"2023","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.reth.2026.101172_bib40","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nature20565","article-title":"In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration","volume":"540","author":"Suzuki","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.reth.2026.101172_bib41","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1093\/nar\/gkv1542","article-title":"In vivo blunt-end cloning through CRISPR\/Cas9-facilitated non-homologous end-joining","volume":"44","author":"Geisinger","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.reth.2026.101172_bib42","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.ymthe.2020.12.010","article-title":"Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration","volume":"29","author":"Bloomer","year":"2021","journal-title":"Mol Ther"},{"key":"10.1016\/j.reth.2026.101172_bib43","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12943-023-01799-7","article-title":"Homology-independent targeted insertion (HITI) enables guided CAR knock-in and efficient clinical scale CAR-T cell manufacturing","volume":"22","author":"Balke-Want","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.reth.2026.101172_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105390","article-title":"Homology-independent targeted insertion-mediated derivation of M1-biased macrophages harbouring Megf10 and CD3\u03b6 from human pluripotent stem cells","volume":"109","author":"Zhen","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.reth.2026.101172_bib45","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1038\/s41598-022-07158-8","article-title":"Transposase-CRISPR mediated targeted integration (TransCRISTI) in the human genome","volume":"12","author":"Rezazade Bazaz","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.reth.2026.101172_bib46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0166-3542(97)00046-6","article-title":"Molecular mechanisms in retrovirus DNA integration","volume":"36","author":"Asante-Appiah","year":"1997","journal-title":"Antivir Res"},{"key":"10.1016\/j.reth.2026.101172_bib47","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s13104-016-2118-z","article-title":"Lentiviral gene transfer into human and murine hematopoietic stem cells: size matters","volume":"9","author":"Cant\u00e9-Barrett","year":"2016","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.reth.2026.101172_bib48","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ymthe.2019.12.009","article-title":"Retroviral insertional mutagenesis in humans: evidence for four genetic mechanisms promoting expansion of cell clones","volume":"28","author":"Bushman","year":"2020","journal-title":"Mol Ther"},{"key":"10.1016\/j.reth.2026.101172_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0020234","article-title":"Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences","volume":"2","author":"Mitchell","year":"2004","journal-title":"PLoS Biol"},{"key":"10.1016\/j.reth.2026.101172_bib50","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1146\/annurev.genet.37.110801.143717","article-title":"Integration of adeno-associated virus (AAV) and recombinant AAV vectors","volume":"38","author":"McCarty","year":"2004","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.reth.2026.101172_bib51","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1128\/JVI.74.10.4612-4620.2000","article-title":"Design and packaging of Adeno-Associated virus gene targeting vectors","volume":"74","author":"Hirata","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.reth.2026.101172_bib52","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41591-019-0344-3","article-title":"Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy","volume":"25","author":"Nelson","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.reth.2026.101172_bib53","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41587-024-02171-w","article-title":"Genome engineering with Cas9 and AAV repair templates generates frequent concatemeric insertions of viral vectors","volume":"43","author":"Suchy","year":"2025","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.reth.2026.101172_bib54","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1038\/s41467-019-12449-2","article-title":"High levels of AAV vector integration into CRISPR-induced DNA breaks","volume":"10","author":"Hanlon","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.reth.2026.101172_bib55","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1089\/hum.2017.038","article-title":"Adeno-Associated virus vectors and stem cells: friends or foes?","volume":"28","author":"Brown","year":"2017","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.reth.2026.101172_bib56","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41434-020-0182-4","article-title":"Limited potential of AAV-mediated gene therapy in transducing human mesenchymal stem cells for bone repair applications","volume":"28","author":"Bougioukli","year":"2021","journal-title":"Gene Ther"},{"key":"10.1016\/j.reth.2026.101172_bib57","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ymthe.2017.11.019","article-title":"Triple vectors expand AAV transfer capacity in the retina","volume":"26","author":"Maddalena","year":"2018","journal-title":"Mol Ther"},{"key":"10.1016\/j.reth.2026.101172_bib58","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkr764","article-title":"Mobilization of giant piggyBac transposons in the mouse genome","volume":"39","author":"Li","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.reth.2026.101172_bib59","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.cell.2005.07.013","article-title":"Efficient transposition of the piggyBac (PB) transposon in Mammalian cells and mice","volume":"122","author":"Ding","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.reth.2026.101172_bib60","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/jmbi.2000.4047","article-title":"Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates1","volume":"302","author":"Izsv\u00e1k","year":"2000","journal-title":"J Mol Biol"},{"key":"10.1016\/j.reth.2026.101172_bib61","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nmeth.1332","article-title":"Transposon-mediated genome manipulation in vertebrates","volume":"6","author":"Ivics","year":"2009","journal-title":"Nat Methods"},{"key":"10.1016\/j.reth.2026.101172_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/srep43613","article-title":"Chromatin states shape insertion profiles of the piggyBac, Tol2 and sleeping Beauty transposons and murine leukemia virus","volume":"7","author":"Yoshida","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.reth.2026.101172_bib63","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf149","article-title":"Structural basis of TnsC oligomerization and transposase recruitment in type I-B CRISPR-associated transposons","volume":"53","author":"Finocchio","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.reth.2026.101172_bib64","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1016\/j.cell.2023.07.010","article-title":"Molecular mechanism for Tn7-like transposon recruitment by a type I-B CRISPR effector","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.reth.2026.101172_bib65","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41587-023-01748-1","article-title":"Targeted DNA integration in human cells without double-strand breaks using CRISPR-associated transposases","volume":"42","author":"Lampe","year":"2024","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.reth.2026.101172_bib66","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41587-020-00745-y","article-title":"CRISPR RNA-guided integrases for high-efficiency, multiplexed bacterial genome engineering","volume":"39","author":"Vo","year":"2021","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.reth.2026.101172_bib67","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1126\/science.aax9181","article-title":"RNA-guided DNA insertion with CRISPR-associated transposases","volume":"365","author":"Strecker","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.reth.2026.101172_bib68","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41586-022-05573-5","article-title":"Structures of the holo CRISPR RNA-guided transposon integration complex","volume":"613","author":"Park","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.reth.2026.101172_bib69","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41587-022-01574-x","article-title":"Precise cut-and-paste DNA insertion using engineered type V-K CRISPR-associated transposases","volume":"41","author":"Tou","year":"2023","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.reth.2026.101172_bib70","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2022.01.013","article-title":"Delivery of CRISPR-Cas tools for in vivo genome editing therapy: trends and challenges","volume":"342","author":"Taha","year":"2022","journal-title":"J Control Release Off J Control Release Soc"},{"key":"10.1016\/j.reth.2026.101172_bib71","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41587-020-0565-5","article-title":"The delivery challenge: fulfilling the promise of therapeutic genome editing","volume":"38","author":"van Haasteren","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.reth.2026.101172_bib72","unstructured":"Allele frequency, n.d.; https:\/\/hla.or.jp\/med\/frequency_search\/en\/allele\/."},{"key":"10.1016\/j.reth.2026.101172_bib73","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s42003-021-02237-4","article-title":"Immunological considerations and challenges for regenerative cellular therapies","volume":"4","author":"Petrus-Reurer","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.reth.2026.101172_bib74","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.molimm.2004.07.028","article-title":"PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis","volume":"42","author":"Pende","year":"2005","journal-title":"Mol Immunol"},{"key":"10.1016\/j.reth.2026.101172_bib75","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.semcancer.2006.07.002","article-title":"The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance","volume":"16","author":"Fuchs","year":"2006","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.reth.2026.101172_bib76","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1196308","article-title":"Loss of DNAM-1 ligand expression by acute myeloid leukemia cells renders them resistant to NK cell killing","volume":"5","author":"Kearney","year":"2016","journal-title":"OncoImmunology"},{"key":"10.1016\/j.reth.2026.101172_bib77","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/icb.2017.59","article-title":"A pro\u2010survival role for the intracellular granzyme B inhibitor Serpinb9 in natural killer cells during poxvirus infection","volume":"95","author":"Mangan","year":"2017","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.reth.2026.101172_bib78","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006364","article-title":"Serpin B9 controls tumor cell killing by CAR T cells","volume":"11","author":"Kimman","year":"2023","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.reth.2026.101172_bib79","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41587-022-01540-7","article-title":"Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression","volume":"41","author":"Gravina","year":"2023","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.reth.2026.101172_bib80","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41587-020-0601-5","article-title":"Engineered off-the-shelf therapeutic T cells resist host immune rejection","volume":"39","author":"Mo","year":"2021","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.reth.2026.101172_bib81","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2024-198684","article-title":"Safety and efficacy of FT522, a First-in-Class, multi-antigen targeted, Off-the-Shelf, iPSC-Derived CD19 CAR NK cell therapy with Alloimmune Defense Receptor (ADR) in Relapsed\/Refractory B-Cell lymphoma","volume":"144","author":"Bachanova","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.reth.2026.101172_bib82","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.4161\/cbt.8.23.10455","article-title":"Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR)","volume":"8","author":"Purdy","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.reth.2026.101172_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/iji.12461","article-title":"Activating killer cell immunoglobulin\u2010like receptors: detection, function and therapeutic use","volume":"47","author":"Blunt","year":"2020","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.reth.2026.101172_bib84","doi-asserted-by":"crossref","first-page":"12000","DOI":"10.1073\/pnas.90.24.12000","article-title":"HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells","volume":"90","author":"Colonna","year":"1993","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.reth.2026.101172_bib85","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1084\/jem.178.2.597","article-title":"P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities","volume":"178","author":"Moretta","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.reth.2026.101172_bib86","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1084\/jem.175.4.885","article-title":"Skin graft rejection by beta 2-microglobulin-deficient mice","volume":"175","author":"Zijlstra","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.reth.2026.101172_bib87","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1038\/s41467-019-13113-5","article-title":"Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants","volume":"10","author":"Koenig","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.reth.2026.101172_bib88","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/s44222-024-00219-9","article-title":"Genetically engineered hypoimmunogenic cell therapy","volume":"2","author":"Hotta","year":"2024","journal-title":"Nat Rev Bioeng"},{"key":"10.1016\/j.reth.2026.101172_bib89","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.omtm.2022.05.010","article-title":"Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical application","volume":"26","author":"Kitano","year":"2022","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.reth.2026.101172_bib90","first-page":"51","article-title":"A clinical-grade HLA haplobank of human induced pluripotent stem cells matching approximately 40% of the Japanese population","volume":"4","author":"Yoshida","year":"2023","journal-title":"Med N Y N"},{"key":"10.1016\/j.reth.2026.101172_bib91","first-page":"1","article-title":"Safety assessment of genome editing in human gene therapy products using next-generation sequencing","year":"2026","journal-title":"Gene Therapy Development"},{"key":"10.1016\/j.reth.2026.101172_bib92","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.tig.2020.10.003","article-title":"Hotspots of Human mutation","volume":"37","author":"Nesta","year":"2021","journal-title":"Trends Genet TIG"},{"key":"10.1016\/j.reth.2026.101172_bib93","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1101\/gr.3677206","article-title":"Copy number variation: new insights in genome diversity","volume":"16","author":"Freeman","year":"2006","journal-title":"Genome Res"},{"key":"10.1016\/j.reth.2026.101172_bib94","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41568-018-0060-1","article-title":"The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers","volume":"18","author":"Sondka","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.reth.2026.101172_bib95","first-page":"1","article-title":"Current perspective on evaluation of tumorigenicity of cellular and tissue-based products derived from induced pluripotent","year":"2013","journal-title":"Stem Cells (iPSCs) and iPSCs as Their Starting Materials"},{"key":"10.1016\/j.reth.2026.101172_bib96","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/scd.2021.0255","article-title":"Distinctive clinical and pathologic features of immature teratomas arising from induced pluripotent stem cell-derived beta cell injection in a diabetes patient","volume":"31","author":"Han","year":"2022","journal-title":"Stem Cell Dev"},{"key":"10.1016\/j.reth.2026.101172_bib97","article-title":"A first-in-human clinical study of an allogenic iPSC-derived corneal endothelial cell substitute transplantation for bullous keratopathy","volume":"6","author":"Hirayama","year":"2025","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.reth.2026.101172_bib98","first-page":"1399","article-title":"Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Rehder","year":"2021","journal-title":"Genet Med Off J Am Coll Med Genet"},{"key":"10.1016\/j.reth.2026.101172_bib99","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41586-023-06490-x","article-title":"The status of the human gene catalogue","volume":"622","author":"Amaral","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.reth.2026.101172_bib100","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.1058040","article-title":"The sequence of the human genome","volume":"291","author":"Venter","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.reth.2026.101172_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2026.102958","article-title":"Comprehensive assessment of on- and off-target mutagenesis via lipid nanoparticle delivery of CRISPR-Cas9 genome editing","volume":"37","author":"Naoe","year":"2026","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.reth.2026.101172_bib102","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41597-021-01077-5","article-title":"Whole genome and exome sequencing reference datasets from a multi-center and cross-platform benchmark study","volume":"8","author":"Zhao","year":"2021","journal-title":"Sci Data"},{"key":"10.1016\/j.reth.2026.101172_bib103","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41586-020-1965-x","article-title":"Analyses of non-coding somatic drivers in 2,658 cancer whole genomes","volume":"578","author":"Rheinbay","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.reth.2026.101172_bib104","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcab008","article-title":"Pan-cancer analysis of non-coding recurrent mutations and their possible involvement in cancer pathogenesis","volume":"3","author":"Kikutake","year":"2021","journal-title":"NAR Cancer"},{"key":"10.1016\/j.reth.2026.101172_bib105","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/humu.22813","article-title":"Comparison of exome and genome sequencing technologies for the complete capture of protein-coding regions","volume":"36","author":"Lelieveld","year":"2015","journal-title":"Hum Mutat"},{"key":"10.1016\/j.reth.2026.101172_bib106","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/s41598-020-59026-y","article-title":"Systematic dissection of biases in whole-exome and whole-genome sequencing reveals major determinants of coding sequence coverage","volume":"10","author":"Barbitoff","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.reth.2026.101172_bib107","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00439-023-02561-1","article-title":"Unintended CRISPR-Cas9 editing outcomes: a review of the detection and prevalence of structural variants generated by gene-editing in human cells","volume":"142","author":"Hunt","year":"2023","journal-title":"Hum Genet"},{"key":"10.1016\/j.reth.2026.101172_bib108","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s40142-013-0012-8","article-title":"Mechanisms for structural variation in the human genome","volume":"1","author":"Currall","year":"2013","journal-title":"Curr Genet Med Rep"},{"key":"10.1016\/j.reth.2026.101172_bib109","doi-asserted-by":"crossref","first-page":"eabo7676","DOI":"10.1126\/sciadv.abo7676","article-title":"Comprehensive analysis and accurate quantification of unintended large gene modifications induced by CRISPR-Cas9 gene editing","volume":"8","author":"Park","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.reth.2026.101172_bib110","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1038\/s41467-023-40901-x","article-title":"Whole genomic analysis reveals atypical non-homologous off-target large structural variants induced by CRISPR-Cas9-mediated genome editing","volume":"14","author":"Tsai","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.reth.2026.101172_bib111","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41467-022-28244-5","article-title":"CRISPR-Cas9 induces large structural variants at on-target and off-target sites in vivo that segregate across generations","volume":"13","author":"H\u00f6ijer","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.reth.2026.101172_bib112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002981","article-title":"De novo CNV formation in mouse embryonic stem cells occurs in the absence of Xrcc4-dependent nonhomologous end joining","volume":"8","author":"Arlt","year":"2012","journal-title":"PLoS Genet"},{"key":"10.1016\/j.reth.2026.101172_bib113","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nrg.2015.25","article-title":"Mechanisms underlying structural variant formation in genomic disorders","volume":"17","author":"Carvalho","year":"2016","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.reth.2026.101172_bib114","first-page":"1","article-title":"Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: international Stem Cell Banking Initiative (ISCBI), Regen","volume":"10","author":"Andrews","year":"2015","journal-title":"M\u00e9d Sur"},{"key":"10.1016\/j.reth.2026.101172_bib115","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","article-title":"Immune responses to viral gene therapy vectors","volume":"28","author":"Shirley","year":"2020","journal-title":"Mol Ther"},{"key":"10.1016\/j.reth.2026.101172_bib116","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","article-title":"Identification of preexisting adaptive immunity to Cas9 proteins in humans","volume":"25","author":"Charlesworth","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.reth.2026.101172_bib117","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1038\/s41467-018-05843-9","article-title":"Cas9 immunity creates challenges for CRISPR gene editing therapies","volume":"9","author":"Crudele","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.reth.2026.101172_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101132","article-title":"PCR-based analytics of gene therapies using adeno-associated virus vectors: considerations for cGMP method development","volume":"31","author":"Blay","year":"2023","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.reth.2026.101172_bib119","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.jcyt.2024.06.005","article-title":"Clearance of residual genome editing components used for ex vivo genome-editing of allogeneic cell therapy products","volume":"26","author":"Chialastri","year":"2024","journal-title":"Cytotherapy"},{"key":"10.1016\/j.reth.2026.101172_bib120","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.3389\/fmicb.2019.01570","article-title":"Accurate quantification and characterization of Adeno-Associated viral vectors","volume":"10","author":"Dobnik","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.reth.2026.101172_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1182209","article-title":"Safety confirmation of induced pluripotent stem cell-derived cardiomyocyte patch transplantation for ischemic cardiomyopathy: first three case reports","volume":"10","author":"Kawamura","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.reth.2026.101172_bib122","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41586-025-08700-0","article-title":"Phase I\/II trial of iPS-cell-derived dopaminergic cells for Parkinson's disease","volume":"641","author":"Sawamoto","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.reth.2026.101172_bib123","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ard.2025.05.453","article-title":"POS0056 CNTY-101, AN iPSC-DERIVED ALLOGENEIC CD19 TARGETING CAR-NK PRODUCT, EXHIBITS ROBUST B CELL DEPLETION AND HAS BROAD POTENTIAL FOR DEVELOPMENT IN B CELL-DRIVEN AUTOIMMUNE DISEASES","volume":"84","author":"Kelly","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reth.2026.101172_bib125","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.2337\/db26-1318-OR","article-title":"1318-OR: CNTY-813: scalable production of allo-evasion 5.0-Engineered IPSC beta islets for off-the-shelf cell therapies","volume":"75","author":"Velazco-Cruz","year":"2026","journal-title":"Diabetes"},{"key":"10.1016\/j.reth.2026.101172_bib124","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1056\/NEJMoa2503822","article-title":"Survival of Transplanted allogeneic beta cells with no immunosuppression","volume":"393","author":"Carlsson","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.reth.2026.101172_bib127","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.stem.2020.02.006","article-title":"How safe are universal pluripotent stem cells?","volume":"26","author":"Gonz\u00e1lez","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.reth.2026.101172_bib128","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.stemcr.2022.02.014","article-title":"Is hypoimmunogenic stem cell therapy safe in times of pandemics?","volume":"17","author":"Matheus","year":"2022","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.reth.2026.101172_bib129","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41586-018-0733-7","article-title":"Linking a cell-division gene and a suicide gene to define and improve cell therapy safety","volume":"563","author":"Liang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.reth.2026.101172_bib130","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/s41587-020-0580-6","article-title":"Metabolic engineering generates a transgene-free safety switch for cell therapy","volume":"38","author":"Wiebking","year":"2020","journal-title":"Nat Biotechnol"}],"container-title":["Regenerative Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320426001136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320426001136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:29:58Z","timestamp":1791862198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352320426001136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":129,"alternative-id":["S2352320426001136"],"URL":"https:\/\/doi.org\/10.1016\/j.reth.2026.101172","relation":{},"ISSN":["2352-3204"],"issn-type":[{"value":"2352-3204","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetically engineered hypoimmunogenic iPSCs: Strategies and considerations for clinical applications","name":"articletitle","label":"Article Title"},{"value":"Regenerative Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reth.2026.101172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier BV on behalf of The Japanese Society for Regenerative Medicine.","name":"copyright","label":"Copyright"}],"article-number":"101172"}}